文献速递技术与安全胸部腹部CT

机会性CT筛查的临床应用、技术基础与最佳实践

Opportunistic CT Screening: Clinical Applications, Technical Foundations, and Best Practices.
PubMed 文献 · Radiographics · 2026-01-01

本文综述了从常规CT检查中提取影像生物标志物的机会性筛查,涵盖低骨密度、肝脂肪变性、肌少症、肥胖及血管钙化等。人工智能与自动化分析拓展了其可行性,但临床推广仍面临工作流整合、标准化与结果解读等挑战。作者总结了常见应用、AI部署要点及质量控制,旨在推动其从概念验证走向可扩展的临床实践。

要点

  • 机会性CT筛查无需额外辐射与扫描时间,可提取骨折风险相关生物标志物。
  • 报告机会性发现时需权衡可操作性,避免过度诊断与不必要的后续检查。
  • 临床整合需关注算法监控、质控及标准化测量技术的部署前评估。

核心结论

  • 机会性CT筛查能从常规检查中提取多种临床相关影像生物标志物,但并非所有标志物都具备同等可操作性。
  • 广泛临床采用受限于工作流整合、标准化、质控、结果可解释性及后续管理价值的不确定性。
  • 需要审慎报告机会性发现,以避免过度诊断和不必要的随访。

研究设计与样本

  • 这是一篇综述,纳入并总结了机会性CT筛查在多种疾病应用中的研究,未报告具体检索范围与纳入文献数量。
  • 文章重点论述自动化及基于人工智能方法的演进,并强调部署前与部署后的质控、算法监控和临床整合考量。

关键影像表现/征象

  • 低骨密度、肝脂肪变性、肌少症、肥胖及血管钙化是常见的机会性CT筛查目标征象。
  • 这些影像征象在常规报告中常被遗漏,但被认为是骨折风险、心血管代谢疾病及衰弱的重要贡献因素。

临床应用与阅片要点

  • 放射科医生应了解机会性发现与骨折、心血管代谢风险及衰弱的相关性,以提升报告价值。
  • 在临床整合前需评估算法性能、标准化测量流程并建立持续监控机制。
  • 报告时机与方式需考虑征象的可操作性,对不明确的结果应避免引发无必要随访。

局限性

  • 机会性影像生物标志物的下游临床管理与临床价值尚存不确定性。
  • 不恰当或不加区分的报告可能导致过度诊断或不必要的后续检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Opportunistic CT screening refers to the extraction of clinically relevant imaging biomarkers from CT examinations routinely performed for unrelated primary indications. This screening does not require additional radiation exposure, imaging time, or patient burden. Advances in automated image analysis and artificial intelligence (AI) have substantially expanded the feasibility of opportunistic CT screening across a range of conditions, including low bone mineral density, hepatic steatosis, sarcopenia, adiposity, and vascular calcifications. These biomarkers are increasingly being recognized as important contributors to fracture risk, cardiometabolic disease, and frailty; yet they often remain undiagnosed in routine clinical practice. While numerous studies have demonstrated technical feasibility and diagnostic performance, widespread clinical adoption of opportunistic CT screening remains limited. Key challenges include those related to workflow integration, standardization of measurement techniques, quality assurance, interpretability of results, and uncertainty regarding downstream clinical management and value. In particular, not all opportunistic imaging biomarkers are equally actionable, and inappropriate or indiscriminate reporting may contribute to overdiagnosis or unnecessary follow-up. The authors summarize common applications of opportunistic CT screening, highlighting typical imaging findings and biomarkers. The authors discuss the evolution of automated and AI-based approaches, with emphasis on practical considerations for deployment, including pre- and postdeployment quality assurance, algorithm monitoring, and practical considerations for clinical integration. Emerging applications also are reviewed, with attention to current limitations. With a focus on clinical integration, this review is intended to inform radiologists, informaticians, and others working in health care systems who seek to translate opportunistic CT screening from proof-of-concept studies into scalable, clinically meaningful practice.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Dogra, Lew, Bussey, et al. Opportunistic CT Screening: Clinical Applications, Technical Foundations, and Best Practices. Radiographics. 2026. PMID: 42752240. doi:10.1148/rg.260009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。